Abstracts Archive - Page 1441 of 2425 - ACR Meeting Abstracts

Abstract Number: 346 • 2016 ACR/ARHP Annual Meeting
Interest of Bone Texture Assessment By Trabecular Bone Score (TBS) in Kidney Transplants Recipients
Marie Aubé¹, Alain Daragon¹, Olivier Vittecoq², Dominique Bertrand³, Mathilde Lemoine³, Jean François Menard⁴ and Christopher Banse⁵, ¹Rheumatology, CHU Hôpitaux de Rouen, Rouen, France, ²Rheumatology, Rouen University Hospital &INSERM U905, Rouen, France, ³Nephrology, CHU Hôpitaux de Rouen, Rouen, France, ⁴Biostatistics, Université de Rouen, Rouen, France, ⁵Rheumatology, Rouen University Hospital, Rouen, France
Background/Purpose: Osteoporosis in kidney transplant is complex and multifactorial. We studied the evolution of Trabecular Bone Score (TBS) and bone mineral density (BMD) in kidney…
Abstract Number: 347 • 2016 ACR/ARHP Annual Meeting
Clinical Analysis of Tumor-Induced Osteomalacia Misdiagnosed As Spondyloarthritis: A Report of 18 Cases
Na Sui¹, Jian Zhu² and Fei Sun¹, ¹Chinese PLA General Hospital, Beijing, China, ²Rheumatology, Chinese PLA General Hospital, Beijing, China
Background/Purpose: To study and summarize the clinical features of tumor-induced osteomalacia(TIO) misdiagnosed as spondyloarthritis(SpA), aiming to explore the reasons of misdiagnosis and raise the correctness…
Abstract Number: 348 • 2016 ACR/ARHP Annual Meeting
Bisphosphonates-Related Atypical Femur Fractures: 8 Years’ Experience in a Single Center
JungHee Koh¹, Seo Hwa Kim², Haneul Kim³, Min Kyung Chung³, Ji Hyeon Ju⁴ and Sung-Hwan Park⁴, ¹Seochogu, Banpodaero, 222, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, ²Division of Rheumatology,, Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, ³Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea, The Republic of, ⁴Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea
Background/Purpose: Patients with rheumatoid arthritis (RA) are diagnosed with osteoporosis earlier than those without, and are therefore exposed to bisphosphonates for longer. However, the increasing…
Abstract Number: 349 • 2016 ACR/ARHP Annual Meeting
Effects of Osteoporosis Treatments for Bone Loss and Pain-Related Behavior in the Hind Limb-Unloaded Mouse Model of Disuse Osteoporosis
Gaku Miyamura¹, Hiroki Wakabayashi², Taro Nakagawa³, Sho Kato², Yohei Naito⁴ and Akihiro Sudo⁵, ¹Department of Orthopaedic surgery, Graduate School of Medicine, Mie University, Tsu,Mie, Japan, ²Department of Orthopaedic Surgery, Graduate School of Medicine, Mie University, Tsu City, Japan, ³Department of Orthopaedic surgery, Graduate School of Medicine, Mie University, Tsu, Japan, ⁴Department of Orthopaedic Surgery, Graduate School of Medicine, Mie University, Tsu City, Mie, Japan, ⁵Department of Orthopaedic surgery, Graduate School of Medicine, Mie University, Tsu-city, Japan
Background/Purpose: Osteoporotic patients with no evidence of fractures sometimes experience vague lower back pain. However, there have been few reports regarding the correlation between…
Abstract Number: 350 • 2016 ACR/ARHP Annual Meeting
Change in Bone Mineral Density with High-Dose Prednisone in Patients with Rheumatoid Arthritis
Linda Rasch¹, Lilian van Tuyl¹, Martijn Kremer², Irene E.M. Bultink², Maarten Boers^3,4 and Willem F. Lems^1,4, ¹Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, ²Rheumatology, Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, ³Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands, ⁴Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, Amsterdam, Netherlands
Background/Purpose: Recently, we showed that treatment with COBRA-light therapy including prednisone with initially 30 mg/day, was as effective as the original COBRA scheme, with initially…
Abstract Number: 351 • 2016 ACR/ARHP Annual Meeting
Pre-Operative Magnetic Resonance Imaging Can Help in Predicting Two-Year Readmission in Acute Severe Osteoporotic Vertebral Fracture after Vertebroplasty
Ying-Chou Chen Sr., Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., YC Chen, Kaohsiung County, Taiwan
Background/Purpose: This study aimed to This study reviewed records of osteoporosis patients with acute vertebral fractures proven by MRI between 2004 and 2007 forlinical informationPrimary…
Abstract Number: 352 • 2016 ACR/ARHP Annual Meeting
Can Lumbar Spine Bone Mineral Density Predict Readmission in Denosumab-Treated Chronic Kidney Disease Patients?
Ying-Chou Chen Sr., Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., YC Chen, Kaohsiung County, Taiwan
Background/Purpose: This study investigated whether bone mineral density (BMD) affects readmission risk in patients with CKD who received denosumab therapy. Methods: All subjects underwent dual…
Abstract Number: 353 • 2016 ACR/ARHP Annual Meeting
Changes in Femoral Neck Bone Mineral Density Inverse Correlate with Egfr in Denosumab Treated Osteoporosis Patients? a Hospital-Based Analysis
Ying-Chou Chen Sr., Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., YC Chen, Kaohsiung County, Taiwan
Background/Purpose: This study investigated the effect of different severities of CKD on bone mineral density (BMD) in patients treated with denosumab. Methods: This study was…
Abstract Number: 354 • 2016 ACR/ARHP Annual Meeting
A Longitudinal Cohort Study of Denosmab and Bisphosphonate for Prevention of Vertebral Fracture in Glucocorticoid-Induced Osteoporosis in Japanese
Ikuko Tanaka¹, Mari Ushikubo², Keisuke Izumi², Kumiko Akiya³ and Hisaji Oshima³, ¹NAGOYA Rheumatology Clinic, Nagoya, Japan, ²Department of Rheumatology, National Tokyo Medical Center, Tokyo, Japan, ³Department of Connective Tissue Diseases, National Tokyo Medical Center, Tokyo, Japan
Background/Purpose: In recent years, denosumab, a monoclonal antibody against RANKL, has been proven for effective treatment of primary osteoporosis. However, effects of denosmab for glucocorticoid-induced…
Abstract Number: 355 • 2016 ACR/ARHP Annual Meeting
Fracture Incidence Rates in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
Raveendhara R. Bannuru¹, Elizaveta Vaysbrot², Mikala Osani², Lenore Buckley³, Howard Fink⁴ and Timothy E. McAlindon⁵, ¹Rheumatology, Tufts Med Ctr, Boston, MA, ²Rheumatology, Tufts Medical Center, Boston, MA, ³Rheumatology, Yale University, North Haven, CT, ⁴Minneapolis VA Health Care System, Washington, DC, ⁵Division of Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Transplants increase risk of bone loss and fractures and reduce quality of life. Information on fracture incidence is important when making clinical decisions about…
Abstract Number: 356 • 2016 ACR/ARHP Annual Meeting
Osteoporotic Fracture As the Main Risk Factor in the Detection of Osteoporosis in Men Under 70 Years
JUAN MARIA BLANCO MADRIGAL^1,2, MARIA LUZ GARCIA VIVAR³, Eva Galindez-Agirregoikoa³, OLAIA BEGOÑA FERNANDEZ BERRIZBEITIA⁴, Itziar Calvo Zorrilla³, Edurne Guerrero Basterretxea³, Esther Ruíz Lucea⁵, Ignacio Torre Salaberri⁶, Lidia Estopiñán-Fortea³, Catalina Gómez Arango⁷ and Amaia Bilbao-González⁸, ¹Rheumatology Department, Basurto University Hospital, VITORIA, Spain, ²Rheumatology, Rheumatology Department, Basurto University Hospital, VITORIA, Spain, ³Rheumatology Department, Basurto University Hospital, Bilbao, Spain, ⁴Rheumatology Department, Basurto University Hospital, BILBAO, Spain, ⁵Rheumatology Department, Basurto University Hospital., Bilbao, Spain, ⁶Rheumatology, Hospital Universitario de Basurto. Bilbao., Bilbao, Spain, ⁷Rheumatology, Rheumatology Department, Basurto University Hospital, Bilbao, Spain, ⁸Research Department, Basurto University Hospital, Bilbao, Spain
Background/Purpose: Osteoporosis (OP) in males under 70 years is less common than postmenopausal and senile, but generates significant social and health costs associated with morbidity…
Abstract Number: 357 • 2016 ACR/ARHP Annual Meeting
Osteoporosis and Breast Cancer: Outcomes at a Specialized Osteoporosis Clinic Following a Structured Assessment
Juan Carlos Ordoñez¹, Salvador López-Salguero¹, Laura Ranieri¹, Mariano Andrés^1,2, Jose Ponce³ and Isabel Ibero¹, ¹RHEUMATOLOGY, HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE, Alicante, Spain, ²Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain, ³ONCOLOGY, HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE, Alicante, Spain
Background/Purpose: Women with breast cancer are at an increased risk for the development of bone loss and osteoporosis mainly due to adjuvant therapies, such as…
Abstract Number: 358 • 2016 ACR/ARHP Annual Meeting
Increased Infection Risk with Concomitant Use of RANK Ligand-Inhibitor, Denosumab and TNF-Inhibitors or Other Biologics: Reality or Illusion? Long Term Experience at the University of Southern California
Purva Chhibar¹ and Glenn Ehresmann², ¹Internal Medicine, Division of Rheumatology, University of Southern California, Keck School of Medicine of USC, Los Angeles, CA, ²Internal Medicine, Division of Rheumatology, University of Southern Californnia, Keck School of Medicine of USC, Los Angeles, CA
Background/Purpose: Patients with autoimmune diseases are at increased risk of early onset osteoporosis due to multiple reasons including prolonged exposure to corticosteroids and the disease…
Abstract Number: 359 • 2016 ACR/ARHP Annual Meeting
The Association of Scheuermann’s Disease with Osteoporotic Vertebral Fracture Risk
Marine Gaudé¹, R Chapurlat² and Pawel Szulc³, ¹Rheumatology, INSERM UMR 1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France, ²INSERM UMR 1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France, ³Epidemiology of Osteoporosis, INSERM UMR 1033, Lyon, France
Background/Purpose: Scheuermann’s disease is one of the most frequent illnesses of the spine in teenagers. Its evolution over time is poorly understood. Spinal deformities, by…
Abstract Number: 360 • 2016 ACR/ARHP Annual Meeting
Osteoporosis Prevalence in Lung Transplant Patients
Mireia Barceló-Bru¹, Sandra Farietta-Varela², Basilio Rodriguez-Díez¹, Ernesto Trallero-Araguás¹, Mireia López-Corbeto², Juan Jose De Agustin De Oro², Roxana Coras² and Agusti Sellas-Fernandez², ¹Rheumatology, Hospital Universitario Vall d´Hebron, Barcelona, Spain, ²Hospital Universitario Vall d´Hebron, Barcelona, Spain
Background/Purpose: Osteoporosis prevalence in lung transplantation candidates is between 16-21%. In the last years, the survival rate after lung transplantation has definitely improved, due to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].